Animal models of human disease. Transgenic and knockout models of autoimmunity: Building a better disease?

Clinical Immunology and Immunopathology

Volumn 79, Issue 2, 1996, Pages 96-104

  Lo, David ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL MODEL; AUTOIMMUNITY; ETIOLOGY; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC ANIMAL;

EID: 0029924544     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0056     Document Type: Article

References (60)

1. Heath, W. R., Allison, J., Hoffmann, J. W., Schonrich, G., Hammerling G., Arnold, B., and Miller, J. F., Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359, 547-549, 1992.
2. Elliott, E. A., and Flavell, R. A., Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes. Int. Immun. 6, 1629-1637, 1994.
3. Allison, J., Oxbrow, L., and Miller, J. F., Consequences of in situ production of IL-2 for islet cell death. Int. Immun. 6, 541-549, 1994.
4. Sarvetnick, N., Liggitt, D., Pitts, S.L., Hansen, S.E., and Stewart, T. A., Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52, 773-782, 1988.
5. Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., Parslow, T., and Stewart, T., Loss of pan creaticislet tolerance induced by beta-cell expression of interferon-gamma. Nature 346, 844-847, 1990.
6. Gu, D., Wogensen, L., Calcutt, N. A., Xiz, C., Zhu, S., Merlie, J. P., Fox, H. S., Lindstrom, J. Powell, H. C. and Sarvetnick, N., Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J. Exp. Med. 181, 547-557, 1995.
7. Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., and Flavell, R. A., Transgenic tumer necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 150, 4136-4150, 1993.
8. Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., and Flavell, R, A., Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas, Proc, Natl, Acad, Sci. USA 89, 10036-10040, 1992.
9. Allison, J., Malcolm, L. Chosich, N., and Miller, J. F., Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells, Eur J, Immunol. 22, 1115-1121, 1992.
10. Dicosmo, B. F., Picarella, D., and Flavell, R. A., Local production of human IL-6 promotes insulitis but retards the enset of insulin-dependent diabetes mellitusm non-obese diabetic mice. Int. Immun. 6, 1829-1837, 1994.
11. Wogensen, L., Huang, X., and Sarvetnick, N., Leukocyteextravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 178, 175-185, 1993.
12. Lee, M. S., Wogensen, L., Shizuru, J., Oldstone, M. B., and Sarvetnick, N., Pancreaticislet production of murine interleukinin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93, 1332-1338, 1994.
13. Wogensen, L., Lee, M. S., and Sarvetnick, N., Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp Med. 179, 1379-1384, 1994.
14. Gu, D., and Sarvetnick, N., Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 118, 33-46, 1993.
15. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R., Interleukin-10 Annu. Rev. Immunol. 11, 165-190, 1993.
16. Bottazzo, G. F., Pujol-Borrell, R., Hanafusa, T., and Feldmann, M., Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2, 1115-1119, 1983.
17. Lo, D., Burkly, L. C., Widera, G., Cowing, C., Flavell, R. A., Palmiter, R. D., and Brinster, R. L., Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53, 159-168, 1988.
18. Bohme, J., Haskins, K., Stecha, P., van Ewijk, W., LeMeur, M. Gerlinger, P., Benoist, and C., Mathis, D., Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 244, 1179-1183, 1989.
19. Miller, J., Daitch, L., Rath, S., and Selsing, E., Tissue-specific tissue rejection nor clonal inactivation of alloreative T cells. J. Immunol. 144, 334-341, 1990.
20. Gotz, J., Eibel, H., and Kohler, G., Non-tolerance and differential susceptibility to diabetes in transgenic mice espressing major histocompatibility class II genes on pancreatic beta cells. Eur J. Immunol. 20, 1677-1683, 1990.
21. Allison, J., Campbell, I. L., Morahan, G., Mandel, T. E., Harrison, L. C., and Miller, J. F., Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature 333, 529-533, 1988.
22. McInerney, M. F., Rath, S., and Janeway, C. A., Jr., Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice. Diabetes 40, 648-651, 1991.
23. Grodsky, G. M., Ma, Y. H., Cullen, B., and Sarvetnick, N., Effect on insulin production sortint and secretetion by major histocompatibility complex class II gene expression in the pancreaticbetacell of transgenic mice. Endocrinology 131, 933-938, 1992.
24. Mandel, T. E., Allison, J., Campbell, I. L., Koulmanda, M., Malcolm, L., Cutri, A., and Miller, J. F., Inherent beta-cell dysfunction induced by transgenic expression of allogeneic major histocompatibility coplex classl antigenin islet cells. Autoimmunity 9, 47-53, 1991.
25. Martin, L., Keller, G. A., Liggitt, D., Oakley, H., Pitts-Meek, S. L., Siege, M. W., Terrell, T., and Stewart, T. A., Male-specific beta-cell dysfunction and diabetes resulting from increased expression of a syngeneic MHC class I protein in the pancreata of transgenic mice. New Biologist 2, 1101-1110, 1990.
26. Wicker, L. S., Todd, J. A., and Peterson, L. B., Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179-200, 1995.
27. Allison, J., Malcolm, L., Culvenor, J., Bartholomeusz, R. K., Holmberg, K., and Miller, J. F., Over expression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion. Proc. Natl. Acad. Sci. USA 88, 2070-2074, 1991.
28. Roman, L. M., Simons, L. F., Hammer, R. E., Sambrook, J. F., and Gething, M. J., The expression of influenzavirus gemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 61, 383-396, 1990.
29. Oldstone, M. B. A., Nerenberg, M., Southern, P., Price, J., and Lewicki, H., Virus infection triggers insulin dependent diabetes mellitus in a transgenic model: role of anti-self virus immune response. Cell 65, 319-331, 1991.
30. Turnley, A. M., Morahan, G., Okano, H., Bernard, O., Mikoshiba, K., Allison, J., Bartlett, P. F., and Miller, J. F., Dysmyelination in transgenic mice resulting from expression of class I hist ocimpatibility molecules in oligodendrocytes. Nature 353, 566-569, 1991.
31. Lo, D., Burkly, L. C., Flavell, R. A., Palmiter, R. D., and Brinster, R. L., Tolerance in transgenic mice expressing class II MHC on pancreatic acinar cells. J. Exp. Med. 170, 87-104, 1989.
32. Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J. P., and Taurog, J. D., spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders. Cell 63, 1099-1112, 1990.
33. Taurog, J. D., Maika, S. D., Simmons, W. A., Breban, M., and Hammer, R. E., Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150, 4168-4178, 1993.
34. Guerder, S., Meyerhoff, J., and Flavell, R., The role of the T cell costimilator B7-1 in autoimmunity, and the induction and maintenance of tolerance to peripheral antigen. Immunity 1, 155-166, 1994.
35. Guerder, S., Picarella, D. E., Linsley, P. S., and Flavell, R. A., Costimulator B7-1 confers antigen-presenting-cell function to patenchymal tissue and in conjunction with tumor nectosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad Sci. USA 92, 5138-5142, 1994.
36. Lee, M. S., von Herrath, M., Reiser, H., Oldstone, M. B., and Sarvetnick, N., Sensitization to self (virus) antigen by in situ expression of murineinterferon-gamma J. Clin. Invest. 95, 486-492, 1995.
37. Katz, J. D., Wang, B., Haskins, K., Benoist, C., and Mathis, D., Following a diabetogenicT cell from genesis through pathogenesis. Cell. 74, 1089-1100, 1993.
38. Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L., and Zaller, D. M., Transgenic mice that express a myelin basic protein-specificT cell receptor develop spontaneous autoimmunity. Cell 72, 551-560, 1993.
39. Lafaille, J. J., Nagashima, K., Katsuki, M., and Tonegawa, S., High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78, 399-408, 1994.
40. Schonrich, G., Kalinke, U., Momburg, F., Malissen, M., Schmit-Verhulst, A. M., Malissen, B., Hammerling, G. J., and Arnold, B., Down regulation of T cell receptors on self reactive T ceells as anovel mechanism for extrathymictolerance induction. Cell 65, 293-304, 1991.
41. Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., and Hengartner, H., Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-317, 1991.
42. Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., and Lo, D., A role for non-MHC genetic polymorphism in susceptiblity to spontaneous autoimmunity, Immunity 1, 73-82, 1994.
43. Degermann, S, Reilly, C., Scott, B., Ogata, L., von Boehmer, H., and Lo, D., On the various manifestations of spontaneous autoimmune diabetes in rodent models. Eur. J. Immunol. 24, 3155-3160, 1994.
44. Fields, L. E., and Loh, D. Y., Organ injury associated with extrathymic induction of immune tolerance in double transgenic mice. Proc. Natl. Acad. Sci. USA. 89, 5730-5734, 1992.
45. Geiger, T., Gooding, L. R., and Flavell, R. A., T-cell responsiveness to an on cogenicperipheral protein and spontaneous autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA. 89, 2985-2989, 1992.
46. Geiger, T., Soldevila, G., and Flavell, R. A., T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets J. Immunol. 151, 7030-7037, 1993.
47. Forster, I., Hirose, R, Arbeit, J. M., Clausen, B. E., and Hanahan, D., Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen. Immunity 2, 573-585, 1995.
48. Nishimoto H., Kikutani, H., Yamamura, K., and Kishimoto, T., Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328, 432-434, 1987.
49. Shull M. M., Ormsby, I., Kier, A. B., Pawlowski, S. Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., and Calvin, D., et al., Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699, 1992.
50. Kulkarni, A. B., Huh C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn M. B., Ward, J. M., and Karlsson, S., Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90, 770-774, 1993.
51. Lo, D., Quill, H., Burkly, L., Scott, B., Palmiter, R. D., and Brinster, R.L., A recessive defect in lymphocyte and/or granulocyte function caused by an integratedtransgene. Am. J. Pathol. 141, 1237-1246, 1992.
52. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Oison, D., Tizard, R., Cate, R., and Lo, D., Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536, 1995.
53. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A., and Bravo, R., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80, 331-340, 1995.
54. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I., Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75, 253-261, 1993.
55. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W., Interleukin-10-deficient mice develop chonic enterocolitis. Cell 75, 263-274, 1993.
56. Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan A.K., and Tonegawa, S., Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 274-282, 1993.
57. Katz, J., Benoist, S., and Mathis, D., Major histocompatibility complex class I molecules are required for the development of insultisin non-obesediabetic mice. Eur. J. Imm. 23, 3358-3360, 1993.
58. Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., Podolin, P. L., Zijlstra, M., Jaenisch, R., and Peterson, L. B., b2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500-504, 1994.
59. n ull mice are diabetes and insulin resistant. Diabetes 43, 505-609, 1994.
60. Sher, A., and Coffman, R. L., Regulation of immunity to parasites by T cells and T-cell-derived cytokines. Annu. Rev. Immunol. 10, 385-409, 1992.